<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Diagnostic dilemma: late presentation of amelanotic BRAF-negative metastatic malignant melanoma resembling clear cell sarcoma: a case report.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Diagnostic dilemma: late presentation of amelanotic BRAF-negative metastatic malignant melanoma resembling clear cell sarcoma: a case report." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222667/bin/1746-1596-8-192-1.jpg"/> </div> <div class="text-side"> <h1>Diagnostic dilemma: late presentation of amelanotic BRAF-negative metastatic malignant melanoma resembling clear cell sarcoma: a case report.</h1> <p>Immunostains of tissue biopsy. (A): 10× H&amp;E; the dermis was infiltrated by sheets and nests of tumor cells with eosinophilic cytoplasm and large nuclei with prominent nucleoli, the epidermis was uninvolved. (B): 20× H&amp;E; higher power of tumor within subcutis shows a nested tumor architecture, neoplastic cells are somewhat discohesive and have bright eosinophilic cytoplasm. (C): 20× S-100; positive nuclear and cytoplasmic reactivity in tumor cells for S-100. (D): 20× HMB-45; positive cytoplasmic reactivity. (E): 20× Melan-A; positive cytoplasmic reactivity. (F): 20× MITF; positive nuclear reactivity.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/24274261/" target="_blank">24274261</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>